Functional clinical outcomes in multiple sclerosis: Current status and future prospects-Reference-Cited by-同舟云学术

Functional clinical outcomes in multiple sclerosis: Current status and future prospects

Published:2015-05 Issue:3 Volume:4 Page:192-201
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Karabudak Rana,Dahdaleh Maurice,Aljumah Mohammed,Alroughani Raed,Alsharoqi I. Ahmed,AlTahan Abdulrahman M.,Bohlega Saeed A.,Daif Abdulkader,Deleu Dirk,Amous Amer,Inshasi Jihad S.,Rieckmann Peter,Sahraian Mohammed A.,Yamout Bassem I.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference91 articles.

1. The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS advisory group;Al-Tahan;Neurosciences,2011

2. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis;Baier;Neurology,2005

3. Contrast letter acuity as a visual component for the multiple sclerosis functional composite;Balcer;Neurology,2003

4. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity;Balcer;Neurology,2010

5. Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS;Balcer;J Neurol Sci,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COGNITIVE IMPAIRMENT IN DIFFERENT CLINICAL FORMS OF MULTIPLE SCLEROSIS;Journal of IMAB - Annual Proceeding (Scientific Papers);2024-06-06

2. Hand Grip Strength as a Predictive Tool for Upper Extremity Functionality, Balance, and Quality of Life in People With Multiple Sclerosis;International Journal of MS Care;2024-05-01

3. The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review;BMC Medical Informatics and Decision Making;2022-09-15

4. Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol;Systematic Reviews;2022-07-01

5. Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis;Multiple Sclerosis and Related Disorders;2022-03